186 related articles for article (PubMed ID: 11943735)
1. Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial function.
Matarrese P; Di Biase L; Santodonato L; Straface E; Mecchia M; Ascione B; Parmiani G; Belardelli F; Ferrantini M; Malorni W
Am J Pathol; 2002 Apr; 160(4):1507-20. PubMed ID: 11943735
[TBL] [Abstract][Full Text] [Related]
2. Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha.
Mecchia M; Matarrese P; Malorni W; D'Agostino G; Sestili P; Santini SM; Gauzzi MC; Venditti M; Mazzocchi A; Parmiani G; Belardelli F; Ferrantini M
Gene Ther; 2000 Jan; 7(2):167-79. PubMed ID: 10673721
[TBL] [Abstract][Full Text] [Related]
3. Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways.
Wang X; Gong Q; Song C; Fang J; Yang Y; Liang X; Huang X; Liu J
Toxicol Appl Pharmacol; 2021 May; 418():115484. PubMed ID: 33716044
[TBL] [Abstract][Full Text] [Related]
4. Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways.
Zhang XD; Gillespie SK; Hersey P
Mol Cancer Ther; 2004 Feb; 3(2):187-97. PubMed ID: 14985459
[TBL] [Abstract][Full Text] [Related]
5. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM
J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045
[TBL] [Abstract][Full Text] [Related]
6. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
7. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of the glycolysis inhibitor 2-deoxy-D-glucose on the activity of pro-apoptotic agents in metastatic melanoma cells, and induction of a cytoprotective autophagic response.
Giammarioli AM; Gambardella L; Barbati C; Pietraforte D; Tinari A; Alberton M; Gnessi L; Griffin RJ; Minetti M; Malorni W
Int J Cancer; 2012 Aug; 131(4):E337-47. PubMed ID: 21913183
[TBL] [Abstract][Full Text] [Related]
9. Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis.
Matarrese P; Testa U; Cauda R; Vella S; Gambardella L; Malorni W
Biochem J; 2001 May; 355(Pt 3):587-95. PubMed ID: 11311119
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
Li H; Niederkorn JY; Neelam S; Alizadeh H
Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
[TBL] [Abstract][Full Text] [Related]
11. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
Kissel CK; Schadendorf D; Röckmann H
Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
[TBL] [Abstract][Full Text] [Related]
12. Sensitization to the mitochondrial pathway of apoptosis augments melanoma tumor cell responses to conventional chemotherapeutic regimens.
Anvekar RA; Asciolla JJ; Lopez-Rivera E; Floros KV; Izadmehr S; Elkholi R; Belbin G; Sikora AG; Chipuk JE
Cell Death Dis; 2012 Nov; 3(11):e420. PubMed ID: 23152056
[TBL] [Abstract][Full Text] [Related]
13. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
14. IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis.
Chawla-Sarkar M; Leaman DW; Jacobs BS; Borden EC
J Immunol; 2002 Jul; 169(2):847-55. PubMed ID: 12097388
[TBL] [Abstract][Full Text] [Related]
15. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions.
Eischen CM; Kottke TJ; Martins LM; Basi GS; Tung JS; Earnshaw WC; Leibson PJ; Kaufmann SH
Blood; 1997 Aug; 90(3):935-43. PubMed ID: 9242521
[TBL] [Abstract][Full Text] [Related]
16. Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK/Parkin/mitophagy axis.
Chen L; Liu L; Li Y; Gao J
In Vitro Cell Dev Biol Anim; 2018 Jan; 54(1):1-10. PubMed ID: 29071589
[TBL] [Abstract][Full Text] [Related]
17. c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.
Biroccio A; Benassi B; Amodei S; Gabellini C; Del Bufalo D; Zupi G
Mol Pharmacol; 2001 Jul; 60(1):174-82. PubMed ID: 11408612
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells.
Selimovic D; Porzig BB; El-Khattouti A; Badura HE; Ahmad M; Ghanjati F; Santourlidis S; Haikel Y; Hassan M
Cell Signal; 2013 Jan; 25(1):308-18. PubMed ID: 23079083
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
20. The MEK1 inhibitor PD98059 sensitizes C8161 melanoma cells to cisplatin-induced apoptosis.
Mandic A; Viktorsson K; Heiden T; Hansson J; Shoshan MC
Melanoma Res; 2001 Feb; 11(1):11-9. PubMed ID: 11254111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
